✦ LIBER ✦

Commentary on “Resistance to Endocrine Therapy of Breast Cancer: Recent Advances and Tomorrow's Challenges”

✍ Scribed by Stephen E. Jones

Book ID: 119615104
Publisher: CIG Media Group, LP.
Year: 2001
Tongue: English
Weight: 61 KB
Volume: 1
Category: Article
ISSN: 1526-8209
DOI: 10.1016/s1526-8209(11)70146-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Resistance to Endocrine Therapy of Breas

Resistance to Endocrine Therapy of Breast Cancer: Recent Advances and Tomorrow's Challenges

✍ Jürgen Geisler; Per Eystein Lønning 📂 Article 📅 2001 🏛 CIG Media Group, LP. 🌐 English ⚖ 285 KB

Mechanisms of Resistance to Endocrine Th

Mechanisms of Resistance to Endocrine Therapy in Breast Cancer: Focus on Signaling Pathways, miRNAs and Genetically Based Resistance

✍ García-Becerra, Rocío; Santos, Nancy; Díaz, Lorenza; Camacho, Javier 📂 Article 📅 2012 🏛 Molecular Diversity Preservation International 🌐 English ⚖ 973 KB

Steroidhormone receptors as targets for

Steroidhormone receptors as targets for the therapy of breast and prostate cancer—recent advances, mechanisms of resistance, and new approaches

✍ J. Hoffmann; A. Sommer 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 184 KB

[Advances in Experimental Medicine and B

[Advances in Experimental Medicine and Biology] Breast Cancer Chemosensitivity Volume 608 || Overview of Resistance to Systemic Therapy in Patients with Breast Cancer

✍ Yu, Dihua; Hung, Mien-Chie 📂 Article 📅 2007 🏛 Springer New York ⚖ 187 KB

Introduction to sessions on guidelines a

Introduction to sessions on guidelines and endocrine therapy, the influence of breast screening on number of mastectomies and the challenge between molecular science and traditional dogma in the treatment of breast cancer. Introduction to Session 6

✍ Gordon C Wishart, Udi Chetty 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 39 KB

[Advances in Pharmacology] Current Chall

[Advances in Pharmacology] Current Challenges in Personalized Cancer Medicine Volume 65 || Histone Deacetylases (HDACs) as Mediators of Resistance to Apoptosis in Melanoma and as Targets for Combination Therapy with Selective BRAF Inhibitors

✍ Lai, Fritz 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 734 KB